At Roseman Law APC, advocacy is more than a professional responsibility; it’s a deeply personal commitment. This year, our team proudly participated in the Breakthrough T1D Walk, an event dedicated to raising awareness and funding for research to cure Type 1 diabetes (T1D). For our firm, this cause hits especially close to home. Our founder and managing partner, Steve Roseman, has a daughter, Danielle, who has been living with Type 1 diabetes for many years. Supporting this mission means supporting families like the Rosemans and millions of others navigating the daily challenges of this lifelong condition.
Team Roseman was honored to walk alongside Danielle and the broader T1D community, standing in solidarity with those who live with this disease every day. Type 1 diabetes requires constant vigilance—monitoring blood sugar, managing insulin, and balancing countless daily factors that affect health and well-being. Despite these challenges, individuals like Danielle continue to show incredible resilience and strength. Events like the Breakthrough T1D Walk remind us of the power of community and the progress that can be made when people come together with a shared goal: a future without T1D.
We are incredibly proud to share that Team Roseman raised over $3,000 through the generosity of our community. Every donation, every participant, and every message of support helped make a meaningful impact in the ongoing fight against Type 1 diabetes. The support we received reflects the compassion and unity of the community around us, and we are deeply grateful to everyone who helped make this effort possible.
At Roseman Law, our commitment to serving people extends beyond the courtroom. Whether we are advocating for our clients or supporting causes that affect families in our community, we believe in standing up for what matters. Participating in the Breakthrough T1D Walk is just one example of how our firm strives to make a difference outside of our legal work. We remain dedicated to raising awareness, supporting critical research, and doing our part to help move the world closer to a cure for Type 1 diabetes.
